Drugs & 
Pill 
Drug Interaction 
Symptom 
Side 
Conditions 
Treatment 
Compare 
My Med 
Discount 
FDA 
Price 
Phonetic 
Health Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Rhapsido (remibrutinib) for the Treatment of Chronic Spontaneous Urticaria
Novartis announced today that Rhapsido® (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult...
FDA Approves Enoby (denosumab-qbde), a Biosimilar to Prolia
Budapest, Hungary and London, UK, 29 September 2025 – Gedeon Richter Plc. (“Richter”) and Hikma Pharmaceuticals Plc. along with its wholly...
FDA Approves Qivigy (immune globulin intravenous, human-kthm) for Primary Humoral Immunodeficiency
Kedrion Biopharma announced today that it has received FDA approval for Qivigy®, a new 10% Immunoglobulin for intravenous use, indicated...
FDA Approves Xtrenbo (denosumab- qbde), a Biosimilar to Xgeva
Budapest, Hungary and London, UK, 29 September 2025 – Gedeon Richter Plc. (“Richter”) and Hikma Pharmaceuticals Plc. along with its wholly...
FDA Approves Palsonify (paltusotine) for the Treatment of Acromegaly in Adults
SAN DIEGO – September 25, 2025 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration...
FDA Approves Inluriyo (imlunestrant) for Adults with ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant, 200 mg tablets),...
Cancer Survival Lower in Rural Areas
Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White individuals...
Telestroke Tied to Higher Odds of Thrombolysis Treatment
Patients with acute ischemic stroke evaluated using telemedicine have higher odds of receiving thrombolysis treatment, but it takes them significantly...
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Loss of Smell May Linger After COVID-19
Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
NIH Awards $50 Million to Top Autism Researchers Despite Political Controversy
WEDNESDAY, Oct. 1, 2025 (HealthDay News) — In a move that surprised many in the scientific community, the National Institutes of Health (NIH) has...
Pfizer Strikes Deal with Trump to Lower Medicaid Drug Costs
WEDNESDAY, Oct. 1, 2025 — The White House has struck a deal with pharmaceutical giant Pfizer Inc. to lower the cost of prescription drugs for the...
New Scorecard Reveals Which States Prepared for Climate Health Threats
WEDNESDAY, Oct. 1, 2025 — A new Commonwealth Fund report offers the first state-by-state ranking of how vulnerable individual health and health care...
HPV Vaccine Protecting Against Infections, Even Among Unvaccinated
WEDNESDAY, Oct. 1, 2025 — The human papillomavirus (HPV) vaccine is protecting women from the cervical-cancer-causing virus — including those...
Longevity Secrets From The World's Oldest Person
FRIDAY, Sept. 26, 2025 — Maria Branyas Morera was the oldest living person in the world when she died at 117 in August 2024, and she passed with...
FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)
The U.S. Food and Drug Administration today removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer...
Recently Added
Recently added consumer and prescribing information: Clotic, Palsonify, Inluriyo, Forzinity, Enbumyst, Inlexzo, Nuvaxovid, mNEXSPIKE, Cyklx, Papzimeos
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Rhapsido Rhapsido (remibrutinib) is a kinase inhibitor indicated for the treatment of chronic spontaneous urticaria (CSU) in adult patients who...
- Enoby Enoby (denosumab-qbde) is a RANK ligand (RANKL) inhibitor biosimilar to Prolia (denosumab) used in the treatment of osteoporosis.
- Qivigy Qivigy (immune globulin intravenous, human-kthm) 10% solution is indicated for treatment of adults with primary humoral immunodeficiency (PI).
Drug Information
Tools
- Interaction Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
Professionals
Top 100 Drugs
- Abilify
- Adderall
- Aimovig
- Ambien
- Atorvastatin
- Austedo
- Avastin
- Benlysta
- Biktarvy
- Botox
- Breztri
- Buprenorphine
- Cabenuva
- Cimzia
- Cosentyx
- Diazepam
- Descovy
- Diclofenac
- Doxycycline
- Duloxetine
- Dupixent
- Emgality
- Enhertu
- Entyvio
- Epclusa
- Erleada
- Evenity
- Fasenra
- Farxiga
- Gabapentin
- Gemtesa
- Humira
- Ibuprofen
- Imbruvica
- Januvia
- Jardiance
- Kesimpta
- Keytruda
- Kisqali
- Leqembi
- Leqvio
- Lexapro
- Lybalvi
- Lyrica
- Metformin
- Methadone
- Methotrexate
- Mounjaro
- Naloxone
- Naltrexone
- Nucala
- Nurtec
- Ofev
- Opdivo
- Orladeyo
- Otezla
- Oxycodone
- Ozempic
- Paxlovid
- Penicillin
- Praluent
- Prednisone
- Prozac
- Qulipta
- Quviviq
- Reblozyl
- Repatha
- Restasis
- Rexulti
- Rybelsus
- Semaglutide
- Seroquel
- Sildenafil
- Skyrizi
- Sotyktu
- Stelara
- Sublocade
- Taltz
- Tepezza
- Tramadol
- Tremfya
- Trintellix
- Tylenol
- Ubrelvy
- Vabysmo
- Venclexta
- Verzenio
- Viagra
- Vijoice
- Vraylar
- Vumerity
- Vyepti
- Vyvanse
- Vyvgart
- Wegovy
- Wellbutrin
- Xanax
- Xolair
- Xyrem
- Zepbound
